Ticker Details
BeiGene, Ltd. American Depositary Shares
IPO Date:	July 25, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$40.07B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$3.96 | 1.40%
Avg Daily Range (30 D):	$4.72 | 1.37%
Avg Daily Range (90 D):	$4.63 | 1.38%

Institutional Daily Volume
Avg Daily Volume:	.03M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.23M

Trade Size
Avg Trade Size (Sh.):	34
Avg Trade Size (Sh.) (30 D):	24
Avg Trade Size (Sh.) (90 D):	23

Institutional Trades
Total Institutional Trades:	436
Avg Institutional Trade:	$6.76M
Avg Institutional Trade (30 D):	$7.03M
Avg Institutional Trade (90 D):	$6.85M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.88M
Avg Closing Trade (30 D):	$7.11M
Avg Closing Trade (90 D):	$7.01M
Avg Closing Volume:	24.66K

News

Feb 12, 2026 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: Na

Jan 29, 2026 @ 5:28 PM FDA Accepts Summit's Lung Cancer Drug Application,... Source: Vandana Singh

Jan 27, 2026 @ 11:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Jan 6, 2026 @ 6:34 PM Ziihera® (zanidatamab-hrii) Combinations Achiev... Source: Zymeworks Inc.

Dec 9, 2025 @ 9:01 PM AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND Source: Prnewswire

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$.09	$.07	$
Diluted EPS	$.08	$.06	$
Revenue	$1.41B	$1.32B	$1.12B
Gross Profit	$1.22B	$1.15B	$952.28M
Net Income / Loss	$124.84M	$94.32M	$1.27M
Operating Income / Loss	$163.11M	$87.89M	$11.1M
Cost of Revenue	$196.51M	$164.61M	$165M
Net Cash Flow	$1.32B	$255.5M	$-108.16M
PE Ratio	4,612.50